Riggs Asset Managment Co. Inc. Tg Therapeutics, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $321 Million
- Q1 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 100 shares of TGTX stock, worth $3,690. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$3,690
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
412Shares Held
87.9MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$576 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$420 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$274 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$121 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$105 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.36B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...